tiprankstipranks
Trending News
More News >
Chia Tai Enterprises International Limited (HK:3839)
:3839
Advertisement

Chia Tai Enterprises International (3839) AI Stock Analysis

Compare
0 Followers

Top Page

HK:3839

Chia Tai Enterprises International

(3839)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 4o)
Rating:69Neutral
Price Target:
HK$9.00
▲(33.93% Upside)
Chia Tai Enterprises International's strong revenue growth and improving profit margins are key strengths, supported by a solid balance sheet. The technical indicators suggest positive momentum, and the valuation indicates potential undervaluation. However, the lack of positive cash flow is a significant risk that needs addressing to sustain growth.

Chia Tai Enterprises International (3839) vs. iShares MSCI Hong Kong ETF (EWH)

Chia Tai Enterprises International Business Overview & Revenue Model

Company DescriptionChia Tai Enterprises International (3839) is a prominent agribusiness company based in Thailand, primarily engaged in the production and distribution of seeds, agricultural products, and related services. The company operates in various sectors, including seed production, crop protection, and agricultural technology. Its core offerings encompass a diverse range of seeds for crops such as vegetables, fruits, and field crops, alongside providing innovative solutions aimed at enhancing agricultural productivity and sustainability.
How the Company Makes MoneyChia Tai Enterprises International generates revenue through multiple streams, primarily from the sale of seeds and agricultural products. The company leverages its extensive research and development initiatives to create high-quality seeds tailored to meet the demands of farmers and agricultural businesses. Additionally, revenue is derived from the provision of crop protection products and agronomic services. Strategic partnerships with agricultural institutions and collaborations with local farmers enhance its market presence and contribute to its earnings. The company also benefits from expanding its distribution networks and entering new markets, which are crucial for driving sales and increasing market share.

Chia Tai Enterprises International Financial Statement Overview

Summary
Chia Tai Enterprises International shows strong revenue growth and improving profit margins, indicating positive operational momentum. The balance sheet is solid with low leverage, suggesting financial stability. However, the absence of positive cash flow is a significant risk, highlighting the need for improved cash management.
Income Statement
70
Positive
Chia Tai Enterprises International has shown a strong revenue growth rate with a significant increase from 2023 to 2024. The gross profit margin stands at 15.90% for 2024, depicting healthy profitability. Additionally, the net profit margin improved to 3.63%, indicating better cost management and operational efficiency. However, there is room for improvement in EBIT and EBITDA margins, which suggest potential for enhanced operational performance.
Balance Sheet
65
Positive
The company's debt-to-equity ratio is 0.29, reflecting a conservative approach to leverage and strong equity financing. The equity ratio is 55.60%, indicating a robust financial position with a substantial portion of assets financed by equity. Return on Equity (ROE) is modest at 4.76% for 2024, suggesting average returns for shareholders. There is a need to enhance asset utilization and profitability to boost ROE.
Cash Flow
50
Neutral
Chia Tai Enterprises International faces challenges in cash flow management, as evidenced by no reported operating or free cash flow for 2024. The absence of positive cash flow suggests potential liquidity constraints. Historically, the company has struggled with consistent free cash flow generation, highlighting the need for improved cash flow efficiency and cost control.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue523.10M307.75M173.98M159.24M142.41M93.58M
Gross Profit72.73M48.93M30.18M39.19M34.76M24.90M
EBITDA39.46M17.51M11.29M5.17M12.38M23.73M
Net Income26.25M11.17M2.55M-6.68M19.56M16.25M
Balance Sheet
Total Assets448.53M422.21M377.37M350.58M365.22M330.70M
Cash, Cash Equivalents and Short-Term Investments35.49M32.38M37.61M30.86M31.09M32.26M
Total Debt59.09M69.17M78.17M49.10M42.61M20.50M
Total Liabilities163.63M161.70M125.36M94.83M81.69M80.09M
Stockholders Equity255.65M234.77M228.43M230.85M253.06M228.00M
Cash Flow
Free Cash Flow0.00-2.56M-27.17M-10.38M-28.46M-9.23M
Operating Cash Flow0.0011.29M-16.06M5.63M-10.91M4.03M
Investing Cash Flow0.00-9.27M-7.14M-15.64M-9.84M-10.87M
Financing Cash Flow0.00-7.07M30.23M10.38M19.36M249.00K

Chia Tai Enterprises International Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price6.72
Price Trends
50DMA
7.86
Negative
100DMA
6.50
Positive
200DMA
4.08
Positive
Market Momentum
MACD
-0.35
Positive
RSI
36.50
Neutral
STOCH
18.00
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3839, the sentiment is Neutral. The current price of 6.72 is below the 20-day moving average (MA) of 7.78, below the 50-day MA of 7.86, and above the 200-day MA of 4.08, indicating a neutral trend. The MACD of -0.35 indicates Positive momentum. The RSI at 36.50 is Neutral, neither overbought nor oversold. The STOCH value of 18.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:3839.

Chia Tai Enterprises International Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
HK$757.29M10.679.75%7.55%-24.96%-26.43%
69
Neutral
$1.79B8.7710.89%161.65%951.04%
63
Neutral
HK$525.14M23.571.87%8.33%-1.99%-81.52%
55
Neutral
HK$500.67M70.630.55%6.74%-4.92%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
49
Neutral
HK$610.24M-40.38%-43.46%-96.48%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:3839
Chia Tai Enterprises International
6.72
5.23
351.01%
HK:0455
Tianda Pharmaceuticals Ltd.
0.12
-0.07
-36.84%
HK:0897
Wai Yuen Tong Medicine Holdings Limited
0.44
0.24
120.00%
HK:1652
Fusen Pharmaceutical Co., Ltd.
0.83
-0.12
-12.63%
HK:0239
Pak Fah Yeow International Limited
2.45
0.13
5.60%
HK:3737
Zhongzhi Pharmaceutical Holdings Limited
0.60
-0.27
-31.03%

Chia Tai Enterprises International Corporate Events

Chia Tai Enterprises Reports Significant Profit Growth Amid Sector Challenges
Oct 21, 2025

Chia Tai Enterprises International Limited announced an expected significant increase in its unaudited consolidated profit for the first nine months of 2025, reaching approximately US$23.5 million compared to US$4.3 million in the same period of 2024. This growth is attributed to a successful strategy to boost sales to key customers. However, the company also reported a decline in quarterly profit due to reduced demand for animal health products amid a slowdown in China’s animal farming sector.

The most recent analyst rating on (HK:3839) stock is a Buy with a HK$10.00 price target. To see the full list of analyst forecasts on Chia Tai Enterprises International stock, see the HK:3839 Stock Forecast page.

Chia Tai Enterprises Reports Strong Interim Results for 2025
Aug 11, 2025

Chia Tai Enterprises International Limited has announced its unaudited consolidated results for the six months ending June 30, 2025. The company reported a significant increase in revenue, reaching US$323.3 million compared to US$108 million in the same period last year. The gross profit also rose to US$41.8 million from US$18 million. The profit attributable to shareholders increased to US$17 million from US$2 million, reflecting a substantial improvement in financial performance. The total comprehensive income for the period was US$24.4 million, a notable turnaround from a loss in the previous year.

Chia Tai Enterprises Schedules Board Meeting for Interim Results and Dividend Decision
Jul 30, 2025

Chia Tai Enterprises International Limited has announced a board meeting scheduled for August 11, 2025, to approve the interim results for the first half of the year ending June 30, 2025. The meeting will also consider the payment of an interim dividend, which could have implications for the company’s financial strategy and shareholder returns.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 23, 2025